Vasculitis & polymyalgia rheumatica

Clonal haematopoiesis across the age spectrum of vasculitis patients with Takayasu’s arteritis, ANCA-associated vasculitis and giant cell arteritis

Ann Rheum DisPublished Cross-sectional study

Authors' conclusion

Age was more strongly associated with CH prevalence than inflammation in systemic vasculitis. Clonal profile was dominated by DNMT3A mutations which were associated with relapse in GCA.

Study context

Population
Patients with three forms of systemic vasculitis (TAK, antibody-associated vasculitis (AAV), giant cell arteritis (GCA)) screened for clonal haematopoiesis (CH) in peripheral blood176 patients · 151 age-matched controls
Participants
70 / 47 / 59 / 151
Exposure
Patients with systemic vasculitis vs age-matched controls
  • TAKn = 70
  • AAVn = 47
  • GCAn = 59
  • Controlsn = 151reference
Outcome
Prevalence of clonal haematopoiesis (CH)
Methodological detailserror-corrected sequencing, multivariable logistic regression, age-matched controls, proteogenomic single-cell DNA sequencing
  • Error-corrected sequencing
  • Multivariable logistic regression
  • Age-matched controls
  • Proteogenomic single-cell DNA sequencing

Main finding

As reported in the abstract

CH prevalence

P < 0.01

CH independently associated with age (standardised B)
0.96
CH independently associated with vasculitis (standardised B)
0.46

Observational data: associations, not effects.

Further findings

Clonal trajectories and cellular activation

Both branched and linear clonal trajectories showed myeloid-lineage bias
CH associated with markers of cellular activation

CH in GCA: temporal artery biopsies and relapse

Mutations detected in temporal artery biopsies
Clinical relapse correlated with CH in a dose-dependent relationship with clone size

Original publication

Clonal haematopoiesis across the age spectrum of vasculitis patients with Takayasu’s arteritis, ANCA-associated vasculitis and giant cell arteritis. Ann Rheum Dis. Published 12 March 2024. doi:10.1136/ard-2023-224933

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.